White Paper: Stem cell therapy for macular degeneration: Current insights and future prospects
11 September 2023
In recent years, the emergence of cell therapy technologies has piqued great interest from researchers and clinicians seeking to develop targeted age-related macular degeneration (AMD) cell therapies. Through cell therapy, functional retinal pigment epithelium (RPE) cells can be transplanted into a patient’s eye to prevent the loss of photoreceptor cells and thus halt the progressive loss of vision. In this whitepaper from Bio-Techne, explore the current landscape of AMD cell therapy, and examine the future prospects and challenges for this exciting emerging technology.